Genentech | Pharma Commons 2012-07-09 07:00:00

When Roche paid $46.8 billion in 2009 to gain full ownership of Genentech, fears were rife that the arrival of the Swiss men in suits would stifle the free-wheeling innovative culture at the Californi…